ngt-pharma-masthead

Customized Solutions for Complex Challenges

NGT Executive Team

Mike K. O'Brien NGT BioPharma Consultants
 
Michael K. O’Brien, PhD
President & CEO

 

Mark Zettler PhD NGT BioPharma Consultants
 
Mark Zettler, PhD
Executive VP Operations

 

Edward Herpel NGT BioPharma Consultants
 
Ed Herpel, MA
Senior VP Organizational & Business Effectiveness

Ronay LeBlanc, MA
VP Quality & Compliance
 
Michael J. Neeb, PhD
VP Pre-Clinical &
Business Development
 
David Lowenschuss, NGT BioPharma Consultants Partner
David Lowenschuss, JD 
VP General Counsel
 
Michelle McGuinness, MA
VP Regulatory Strategy & Submissions

Rachel Franckowiak, BA
Senior Executive Administrator

NGT Scientific and Professional Services Team


Alton Johnson, PhD
Manufacturing Operations,
Drug Development
Malcolm Berry, PhD - Multi-Stage Continuous Processing for APIs
 
Malcolm Berry, PhD
API Continuous Processing

Nancy C. Motola, PhD, RAC
Regulatory, Compliance, Quality Assurance
Michael Placke, NGT Biopharma Consultants
 
Michael Placke, PhD, DABT
Nonclinical Development
and Drug Safety

Leo Adalbert, NGT BioPharma Consultants

 
Leo J. Adalbert
Principal Consultant –
Strategic Commercialization

 
John L. Dillon, PhD
API Process R&D, Synthetic Organic Chemistry
 
Jeff Brum, PhD
Pharmaceutical Analysis – CMC Product Development

Robert Dennehy, PhD
API Crystallization and Solid State
 
Steve Hammond
Process Analytics and
PAT Innovator
 
Philip Chu, PhD
Associate Consultant
 
Paul E. Luner, PhD
Oral Formulation Development & Physical Pharmaceutics
 
Frank P. Orlowski, MBA
Biotech and Life Sciences
Global Finance